Management of muscle wasting in cancer-associated cachexia
- 15 September 2001
- Vol. 92 (S6) , 1669-1677
- https://doi.org/10.1002/1097-0142(20010915)92:6+<1669::aid-cncr1495>3.0.co;2-s
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Anabolic steroidsCurrent Opinion in Clinical Nutrition and Metabolic Care, 1999
- CYTOKINE LEVELS (IL-6 AND IFN-γ), ACUTE PHASE RESPONSE AND NUTRITIONAL STATUS AS PROGNOSTIC FACTORS IN LUNG CANCERCytokine, 1999
- Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout miceMolecular and Cellular Endocrinology, 1998
- New cachexic factorsCurrent Opinion in Clinical Nutrition and Metabolic Care, 1998
- Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles.Journal of Clinical Investigation, 1997
- Comparative effects of β2-adrenergic agonists on muscle waste associated with tumour growthCancer Letters, 1997
- Characterization of a cancer cachectic factorNature, 1996
- Insulin sensitivity, hormonal levels and skeletal muscle protein metabolism in tumour-bearing exercising ratsEuropean Journal Of Cancer, 1995
- Growth hormone, insulin, and somatostatin therapy of cancer cachexiaCancer, 1994
- Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.Journal of Clinical Investigation, 1993